Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC

Condition:   Breast Cancer Interventions:   Drug: Ribociclib;   Other: Mono-chemotherapy;   Other: Endocrine-Therapy Sponsors:   Swiss Group for Clinical Cancer Research;   The Belgian Society of Medical Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials